Prostaglandin D2and the role of the DP1, DP2and TP receptors in the control of airway reflex events

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1108-1118

  Maher, Sarah A ^a   Birrell, Mark A ^a   Adcock, John J ^a   Wortley, Michael A ^a   Dubuis, Eric D ^a   Bonvini, Sara J ^a   Grace, Megan S ^a   Belvisi, Maria G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG; CAPSAICIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; INDOLE DERIVATIVE; MK-0524; TFDP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BIOASSAY; BREATHING REFLEX; CONTROLLED STUDY; COUGHING; DRUG ANTAGONISM; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE; VAGUS NERVE; ANIMAL; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; BRONCHOSPASM; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GUINEA PIG; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUE;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL SPASM; CAPSAICIN; CELLS, CULTURED; COUGH; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GUINEA PIGS; HUMANS; INDOLES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; VAGUS NERVE;

EID: 84926460525     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00061614     Document Type: Article

References (47)

1. Lewis RA, Soter NA, Diamond PT, et al. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982; 129: 1627-1631.
2. Oelz O, Oelz R, Knapp HR, et al. Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins 1977; 13: 225-234.
3. MacDermot J, Kelsey CR, Waddell KA, et al. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins 1984; 27: 163-179.
4. Tanaka K, Ogawa K, Sugamura K, et al. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 2000; 164: 2277-2280.
5. Crea AE, Nakhosteen JA, Lee TH. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. Eur Respir J 1992; 5: 190-195.
6. Liu MC, Bleecker ER, Lichtenstein LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990; 142: 126-132.
7. Murray JJ, Tonnel AB, Brash AR, et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315: 800-804.
8. Wenzel SE, Westcott JY, Smith HR, et al. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989; 139: 450-457.
9. Marom Z, Shelhamer JH, Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest 1981; 67: 1695-1702.
10. Flower RJ, Harvey EA, Kingston WP. Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol 1976; 56: 229-233.
11. Alving K, Matran R, Lundberg JM. The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. Acta Physiol Scand 1991; 143: 93-103.
12. Hardy CC, Robinson C, Tattersfield AE, et al. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984; 311: 209-213.
13. Sampson SE, Sampson AP, Costello JF. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. Thorax 1997; 52: 513-518.
14. Monneret G, Gravel S, Diamond M, et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001; 98: 1942-1948.
15. Woodward DF, Jones RL, Narumiya S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 2011; 63: 471-538.
16. Pettipher R, Whittaker M. Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis. J Med Chem 2012; 55: 2915-2931.
17. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990; 86: 924-935.
18. Gardiner PJ, Browne JL. Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved. Prostaglandins Leukot Med 1984; 14: 153-159.
19. Birring SS, Parker D, Brightling CE, et al. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 2004; 169: 15-19.
20. Birrell MA, Belvisi MG, Grace M, et al. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med 2009; 180: 1042-1047.
21. Grace M, Birrell M, Dubuis E, et al. Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin. Thorax 2012; 67: 891-900.
22. Maher SA, Birrell MA, Belvisi MG. Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med 2009; 180: 923-928.
23. Birrell M, Wong S, McCluskie K, et al. Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways. J Pharmacol Exp Ther 2006; 316: 1318-1327.
24. Adcock JJ, Douglas GJ, Garabette M, et al. RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br J Pharmacol 2003; 138: 407-416.
25. Lalloo UG, Fox AJ, Belvisi MG, et al. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol 1995; 79: 1082-1087.
26. Laude EA, Higgins KS, Morice AH. A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in guinea-pig and man. Pulm Pharmacol 1993; 6: 171-175.
27. Matsuoka T. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287: 2013-2017.
28. Arimura A, Yasui K, Kishino J, et al. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 2001; 298: 411-419.
29. Mansur AH, Bishop DT, Holgate ST, et al. Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma. Thorax 2004; 59: 876-882.
30. Oguma T, Palmer LJ, Birben E, et al. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med 2004; 351: 1752-1763.
31. Brightling CE. Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung 2010; 188: Suppl. 1, S13-S17.
32. Al Jarad N, Hui KP, Barnes N. Effects of a thromboxane receptor antagonist on prostaglandin D2 and histamine induced bronchoconstriction in man. Br J Clin Pharmacol 1994; 37: 97-100.
33. 2 in the cough response in guinea-pigs: antitussive effect of ozagrel. Br J Pharmacol 2000; 131: 266-270.
34. Beasley RC, Featherstone RL, Church MK, et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J Appl Physiol 1989; 66: 1685-1693.
35. Boie Y, Sawyer N, Slipetz DM, et al. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995; 270: 18910-18916.
36. Hirata M, Kakizuka A, Aizawa M, et al. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 1994; 91: 11192-11196.
37. 2-agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway. Eur Respir J 2010; 35: 647-654.
38. Zaccolo M. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol 2009; 158: 50-60.
39. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411: 957-962.
40. Wang S, Dai Y, Fukuoka T, et al. Phospholipase C and protein kinase A mediate bradykinin sensitisation of TRPA1: a molecular mechanism of inflammatory pain. Brain 2008; 131: 1241-1251.
41. Bessac BF, Jordt SE. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology 2008; 23: 360-370.
42. Sawyer N, Cauchon E, Chateauneuf A, et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002; 137: 1163-1172.
43. +currents in DRG neurons of adult rat. Pain 2011; 152: 1114-1126.
44. Choudry NB, Fuller RW, Pride NB. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 1989; 140: 137-141.
45. Philip G, van Adelsberg J, Loeys T, et al. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. J Allergy Clin Immunol 2009; 124: 942-948.
46. Sunger K, Powley W, Kelsall A, et al. Objective measurement of cough in otherwise healthy volunteers with acute cough. Eur Respir J 2013; 41: 277-284.
47. Marsden PA, Smith JA, Kelsall AA, et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol 2008; 122: 903-907.